Singapore markets open in 3 hours 58 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.1000+0.0400 (+1.94%)
At close: 03:41PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 42.76M
Enterprise value 82.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.50
Price/book (mrq)1.76
Enterprise value/revenue 1.06
Enterprise value/EBITDA -9.87

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-66.06%
S&P500 52-week change 314.56%
52-week high 37.7600
52-week low 31.5400
50-day moving average 32.1669
200-day moving average 33.9098

Share statistics

Avg vol (3-month) 317.32k
Avg vol (10-day) 37.84k
Shares outstanding 519.67M
Implied shares outstanding 6N/A
Float 816.36M
% held by insiders 110.02%
% held by institutions 17.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Dec 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2021
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin -25.58%
Operating margin (ttm)-16.82%

Management effectiveness

Return on assets (ttm)-6.25%
Return on equity (ttm)-92.41%

Income statement

Revenue (ttm)77.06M
Revenue per share (ttm)4.39
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)47.48M
EBITDA -7.29M
Net income avi to common (ttm)-19.71M
Diluted EPS (ttm)-1.1230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.14M
Total cash per share (mrq)0.41
Total debt (mrq)47.39M
Total debt/equity (mrq)197.55
Current ratio (mrq)1.02
Book value per share (mrq)1.23

Cash flow statement

Operating cash flow (ttm)-1.22M
Levered free cash flow (ttm)-16.08M